First Episealer® Talus surgery in Scandinavia performed
Episurf Medical (Nasdaq: EPIS B) today announces that the first Episealer® Talus surgery in Scandinavia was performed earlier today at the Arcademy Clinic at Sophiahemmet, Stockholm, Sweden. The surgery was performed by Dr Jouko Kivioja and his team, supported by Prof. Niek van Dijk from the FIFA Medical Center of Excellence, Madrid, Spain.
”Arcademy is a center of excellence at Sophiahemmet hospital with a vision to lead and improve surgery and healthcare. Performing the first Episealer® Talus surgery in Scandinavia today is an example of how we constantly strive for excellence. The patient has suffered for a long time due to a large injury in his ankle joint, which we today have resolved with an Episealer® Talus implant”, says Dr Jouko Kivioja.
“We are very pleased with the cooperation with the team at the Arcademy Clinic, leading up to this first Episealer® Talus surgery in Scandinavia. We look forward to continued cooperation, and we hope to offer this implant solution to many more patients in Sweden and other countries. I also want to congratulate Dr Kivioja and his team on a successful surgery”, says Pål Ryfors, CEO Episurf Medical.
"We are proud of Dr Jouko Kivioja, Consultant Orthopaedic Surgeon at the Arcademy clinic, Sophiahemmet. Today, he has performed the first surgery in Scandinavia for a large lesion in an ankle, for which an individualised implant, an Episealer® Talus implant, has been used to repair the lesion", says Dr Elisabet Hagert, CEO Arcademy Clinic.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
Tags:
